The early predictive factors of hypocalcemia in patients undergoing total thyroidectomy or completion thyroidectomy.
Not Applicable
- Conditions
- Health Condition 1: C73- Malignant neoplasm of thyroid gland
- Registration Number
- CTRI/2021/08/035393
- Lead Sponsor
- AIIMS New Delhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patient planned for total thyroidectomy with or without neck dissection.
Patient giving consent to participate in study.
Patient planned for completion thyroidectomy.
Exclusion Criteria
Patient who is not willing to participate in the study
Patient is unfit for surgery under general anesthesia.
Patient having inoperable primary disease of thyroid.
Patient having secondary hypoparathyroidism
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate the role of absolute iPTH decline and absolute serum ionised calcium decline at 1 hour and 1 day post thyroidectomy in predicting hypocalcemia. <br/ ><br> <br/ ><br>To evaluate the role of serum magnesium levels in post-thyroidectomy hypocalcemia <br/ ><br>Timepoint: To evaluate the role of absolute iPTH decline and absolute serum ionised calcium decline at 1 hour and 1 day post thyroidectomy in predicting hypocalcemia. <br/ ><br> <br/ ><br>To evaluate the role of serum magnesium levels in post-thyroidectomy hypocalcemia <br/ ><br>
- Secondary Outcome Measures
Name Time Method To develop a composite scoring system for predicting patients at high risk for developing significant hypocalcemia in post-operative period <br/ ><br> <br/ ><br>To develop a protocol for initiating calcium and vitamin D supplementation based on biochemical results. <br/ ><br> <br/ ><br>To correlate Bethesda scoring system for thyroid cytopathology and TI-RADS system for thyroid lesion with histopathology <br/ ><br>Timepoint: At post operative day 0 and 1